Clinical Trials Logo

Hyperoxia clinical trials

View clinical trials related to Hyperoxia.

Filter by:

NCT ID: NCT03930979 Completed - Hyperoxia Clinical Trials

The Effect of Hyperoxia on Cardiac Output

Start date: May 1, 2018
Phase:
Study type: Observational [Patient Registry]

Rational: Preoxygenation is a standard procedure before (deep) sedation in the ED. However, there is literature suggesting that too much oxygen can be harmful. One potential detrimental effect is a decrease in cardiac output due to coronary vasoconstriction. So far, it is unknown if this effect is rate dependent and if it also occurs after only a short period of hyperoxia, as patients experience during procedural sedation pre-oxygenation. Objective: To investigate if hyperoxia has a negative effect on Cardiac index (CI) in patients undergoing procedural sedation in the ED.

NCT ID: NCT03754985 Completed - Hyperoxia Clinical Trials

Hyperbaric Oxygen Therapy Effects on Pulmonary Functions

PulmHBOT
Start date: January 2016
Phase:
Study type: Observational

Prospective analysis included patients, 18 years or older, scheduled for 60 daily HBOT sessions between 2016-2018. Each session was 90 min of 100% oxygen at 2 ATA with 5 minutes air breaks every 20 min, five days per week. Pulmonary functions,measured at baseline and after HBOT,included forced vital capacity (FVC), forced expiratory volume in one second (FEV1), peak expiratory flow rate (PEF).

NCT ID: NCT03661086 Completed - Respiratory Failure Clinical Trials

Oxygen Control and Weaning by O2matic to Patients Admitted With an Exacerbation of COPD

O2MATIC-WEAN
Start date: December 1, 2018
Phase: N/A
Study type: Interventional

The aim of the study is to examine if automated oxygen delivery with O2matic allows for faster weaning from oxygen and better oxygen control than manually controlled oxygen therapy for patients admitted with an exacerbation of chronic obstructive pulmonary disease (COPD). Furthermore it will be tested if O2matic compared to manual control allows for faster discharge from hospital. Patients sense of security, anxiety and dyspnea will be evaluated by questionnaires.

NCT ID: NCT03653325 Completed - Clinical trials for Out-Of-Hospital Cardiac Arrest

ORI to Reduce Hyperoxia After Out Hospital Cardiac Arrest

ORI-ONE
Start date: November 8, 2018
Phase: N/A
Study type: Interventional

The investigator's research proposal is a randomized controlled study evaluating two different monitoring strategies to titrate FiO2 in order to rapidly and safely achieve optimal SatO2 targets during early ROSC of non-traumatic OHCA in adults. Primary hypothesis: Monitoring transport to hospital of sustained ROSC of OHCA patients using multiple wavelength detectors that allow ORI continuous measurement will reduce hyperoxia and hypoxia burden associated with transport. Secondary hypothesis: Multiple wavelength detectors allowing ORI continuous measurement will reduce hyperoxia at ER admission as measured via blood gas analysis. Tertiary study hypothesis: Multiple wavelength detectors allowing ORI continuous measurement will reduce reperfusion neuronal injury measured through NSE levels at 48h post ROSC

NCT ID: NCT03620370 Completed - Stroke, Acute Clinical Trials

Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke

Start date: August 12, 2018
Phase: N/A
Study type: Interventional

NBO is a nonpharmacological measure of neuroprotection. The purpose of our study is to evaluate the safety and efficiency of NBO(Normobaric hyperoxia) in the acute ischemic stroke patients who received endovascular treatment. Looking for more clinical evidence for the ischemic stroke patients who will be treated with NBO in the future.

NCT ID: NCT03571074 Completed - Cardiac Arrest Clinical Trials

Hyperoxia Before and After Cardiac Arrest and Myocardial Damage

Start date: May 30, 2018
Phase:
Study type: Observational

Several studies show how patients with hyperoxia after cardiac arrest has increased mortality, but the association of hyperoxia before cardiac arrest and myocardial damage has never been investigated. Neither has the association between hyperoxia after cardiac arrest and myocardial injury. Our research hypothesis is that hyperoxia before cardiac arrest aggravates myocardial damage, secondly we wish to analyze the association between hyperoxia after cardiac arrest and myocardial injury. The exposure variables is oxygenation within 48 hours before and 48 hours after cardiac arrest, our primary outcome is myocardial damage and will be measured as peak troponin within 30 days after cardiac arrest.

NCT ID: NCT03494387 Completed - Clinical trials for Postoperative Cardiac Complication

VitamIn and oXygen Interventions and Cardiovascular Events

VIXIE
Start date: April 6, 2018
Phase: Phase 4
Study type: Interventional

This study examines the risks and benefits of antioxidants and normal versus high inspiratory oxygen fraction during anaesthesia.

NCT ID: NCT03488238 Completed - Hyperoxia Clinical Trials

Correlation of Changes in PaO2 and ORi in Adult Patients

Start date: August 1, 2018
Phase:
Study type: Interventional

The Oxygen Reserve Index (ORi) is a reference that could help clinicians with their assessments of normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to PaO2 values of 100mmHg and below and an ORi of 1.00 corresponds to PaO2 values of 200mmHg and above. This is a prospective, non-blinded, non-randomized study of the Oxygen Reserve Index (ORi) in a clinical setting. It is designed to evaluate the correlations with ORi and changes in PaO2 and the potential use of ORi as an early warning of impending arterial oxygen desaturation.

NCT ID: NCT03464695 Completed - Respiratory Failure Clinical Trials

Automated Oxygen Delivery by O2matic to Patients Admitted With an Exacerbation in COPD

O2MATIC
Start date: May 7, 2018
Phase: N/A
Study type: Interventional

The aim of the study is to examine if automated oxygen delivery with O2matic is better than manually controlled oxygen therapy for patients admitted to hospital with an exacerbation in Chronic Obstructive Pulmonary Disease (COPD). O2matic is a closed -loop system based on continuous non-invasive measurement of pulse and oxygen-saturation that is processed in an algorithm that controls the flow of oxygen to the patient. The primary hypothesis is that O2matic increases time within acceptable oxygen-saturation interval. Secondary hypotheses are that O2matic compared to manual control reduces time with severe hypoxia (SpO2 < 85 %), hypoxi (SpO2 below intended interval) and hyperoxia (SpO2 above intended interval).

NCT ID: NCT03433261 Completed - Clinical trials for CNS Oxygen Toxicity, Ketogenic Diet

Ketogenic Diet for Reduction of CNS Oxygen Toxicity in Working Divers

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this research study is to understand the effect of nutritional ketosis on CNS oxygen toxicity in undersea divers. The investigators hope this will provide a starting point to develop methods for improving the safety of Navy divers, warfighters and submariners.